NCT07416188 2026-04-17
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Not yet recruiting
National Institutes of Health Clinical Center (CC)
Cancer Research UK
Vastra Gotaland Region